Filter
832
Filtered Results: 832
Text search:
vaccine
readiness
Featured
Recommendations
123
New Publications
222
Language
Document type
No document type
339
Guidelines
150
Studies & Reports
125
Strategic & Response Plan
83
Manuals
64
Fact sheets
28
Situation Updates
19
Training Material
11
Resource Platforms
9
Online Courses
2
App
1
Infographics
1
Countries / Regions
Global
41
India
38
Kenya
33
Sierra Leone
23
Nigeria
21
Ethiopia
17
Liberia
17
Nepal
16
Syria
15
Africa
15
Congo, Democratic Republic of
15
Tanzania
14
Bangladesh
14
South Africa
13
Latin America and the Carribbean
11
Russia
11
Ghana
10
Malawi
10
Uganda
10
Myanmar / Burma
10
Ukraine
9
Zambia
9
Rwanda
8
Western and Central Europe
8
East and Southern Africa
8
Pakistan
8
Senegal
7
West and Central Africa
7
South–East Asia Region
7
Philippines
6
Mozambique
6
Middle East and North Africa
6
Western Pacific Region
6
Brazil
6
South Sudan
6
Afghanistan
5
Zimbabwe
5
Guinea
5
Eastern Europe and Central Asia
5
Indonesia
5
Lesotho
4
Namibia
4
Benin
3
Burundi
3
Moldova
3
Yemen
3
Central African Republic
3
Mali
3
Somalia
3
Eswatini/ Swaziland
3
Thailand
2
Turkey
2
China
2
Cameroon
2
Côte d’Ivoire / Ivory Coast
2
Eastern Europe
2
Botswana
2
Timor Leste/ East Timor
1
El Salvador
1
Chile
1
Burkina Faso
1
Malaysia
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
Turkmenistan
1
Japan
1
Mauritius
1
Spain
1
Southern Africa
1
Lebanon
1
Vietnam
1
Egypt
1
Sudan
1
Georgia
1
Angola
1
Chad
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
354
Clinical Guidelines
60
Public Health
49
Key Resources
43
Women & Child Health
34
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
COVID-19
222
Rapid Response
70
Ebola
40
HIV
30
Conflict
23
AMR
18
TB
16
Polio
15
Caregiver
13
Global Health Education
11
Cholera
9
Natural Hazards
8
Health Financing Toolbox
8
Planetary Health
7
Pharmacy
7
Zika
7
NTDs
6
Refugee
5
NCDs
5
Mental Health
3
Specific Hazards
2
Disability
1
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera...
DHS Further Analysis Reports No. 115
Fair global distribution of COVID-19 vaccines
recommended
MEDBOX Issue Brief no.9 ,1 Febr. 2021
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
WHO Secretariat Information paper July 2016
This guidance has been developed in line with the WHO corporate risk management framework, the WHO business continuity and contingency plans, as well as the Inter-Agency Emergency Response Preparedness Framework. It is based on a common organiza-tional approach and procedures for managing including ...
Risk of spill-over of EVD to Uganda has been categorised as very high. On 28 September 2018, WHO elevated the risk at the regional level which includes Uganda from ‘high’ to ‘very high’. Uganda has a very long and largely porous border with the DRC. High population movements across the borde...
Explainer for countries based on commonly asked questions
12 November 2020
This document aims to explain how COVAX vaccines will be allocated amongst participants.
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Toolkit regarding Zika Virus
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o...
8 February 2021
Risk Communication and Community Engagement (RCCE) is an essential part of any disease outbreak response. Risk communication in the context of an Ebola outbreak refers to real time exchange of information, opinion and advice between frontline responders and people who are faced with the threat of Eb...
